Showing 13,081 - 13,100 results of 36,913 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 100 ((teer decrease) OR (a decrease)) ))', query time: 1.13s Refine Results
  1. 13081

    Table_2_Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid.docx by Stanislav Khil'chenko (9333356)

    Published 2020
    “…Serum Ig concentrations were determined by ELISA in 105 healthy controls, 100 pemphigus vulgaris (PV), 100 pemphigus foliaceus, 99 bullous pemphigoid (BP), and 55 linear IgA bullous dermatosis (LAD) patients. …”
  2. 13082

    Table_1_Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid.xlsx by Stanislav Khil'chenko (9333356)

    Published 2020
    “…Serum Ig concentrations were determined by ELISA in 105 healthy controls, 100 pemphigus vulgaris (PV), 100 pemphigus foliaceus, 99 bullous pemphigoid (BP), and 55 linear IgA bullous dermatosis (LAD) patients. …”
  3. 13083
  4. 13084

    DataSheet_2_Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination.docx by Yifei Ma (206062)

    Published 2023
    “…Median chemotherapy time was 7 (quartile, 5–11) months. In PSM sample pairs, the humoral response of CCP against variants was significantly decreased, and serology titers (281.8 ± 315.5 U/ml) were reduced, as compared to ACP (p< 0.01 for the rate of neutralization rate against each variant) and CHC (p< 0.01 for the rate of neutralization against each variant) groups. …”
  5. 13085

    DataSheet_1_Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination.docx by Yifei Ma (206062)

    Published 2023
    “…Median chemotherapy time was 7 (quartile, 5–11) months. In PSM sample pairs, the humoral response of CCP against variants was significantly decreased, and serology titers (281.8 ± 315.5 U/ml) were reduced, as compared to ACP (p< 0.01 for the rate of neutralization rate against each variant) and CHC (p< 0.01 for the rate of neutralization against each variant) groups. …”
  6. 13086

    <i>E. coli</i> K1 binds to FcγRIa via OmpA and induces a distinct signaling. by Rahul Mittal (202639)

    Published 2010
    “…After one hour of incubation, the cells were washed and OmpA+ <i>E. coli</i> were added at an MOI of 10 and 100. …”
  7. 13087

    Original data. by Kenji Sato (657309)

    Published 2024
    “…The mean (SD) time from discharge to the start of rehabilitation was 4 (4) days. …”
  8. 13088

    Home-based rehabilitation program. by Kenji Sato (657309)

    Published 2024
    “…The mean (SD) time from discharge to the start of rehabilitation was 4 (4) days. …”
  9. 13089

    Baseline characteristics of study participants. by Kenji Sato (657309)

    Published 2024
    “…The mean (SD) time from discharge to the start of rehabilitation was 4 (4) days. …”
  10. 13090

    Spatial characteristics of boundary vector cells. by Lear Cohen (15353793)

    Published 2023
    “…<b>(A)</b> 2D correlation coefficient of firing rate and the fish’s position of the cell (red dot) and 5,000 shuffled spike trains (gray dots, the 97.5 percentile is depicted), suggesting this cell had a left boundary tuning. …”
  11. 13091
  12. 13092

    Antepartum fibrinogen concentration as a predictor of bleeding complications by Laura E. Dodge (7875416)

    Published 2019
    “…For every 100-mg/dL decrease in fibrinogen, the odds of a bleeding complication increased 1.63 times (95% confidence interval: 1.48–1.80). …”
  13. 13093
  14. 13094
  15. 13095
  16. 13096
  17. 13097
  18. 13098

    The 2014–2015 Ebola virus disease outbreak and primary healthcare delivery in Liberia: Time-series analyses for 2010–2016 by Bradley H. Wagenaar (311527)

    Published 2018
    “…Decreases in outputs comparing the end of the initial EVD period (September 2014) to May 2014 (pre-EVD) ranged in magnitude from a 67.3% decrease in measles vaccinations (95% CI: −77.9%, −56.8%, <i>p <</i> 0.001) and a 61.4% decrease in artemisinin-based combination therapy (ACT) treatments for malaria (95% CI: −69.0%, −53.8%, <i>p <</i> 0.001) to a 35.2% decrease in first antenatal care (ANC) visits (95% CI: −45.8%, −24.7%, <i>p <</i> 0.001) and a 38.5% decrease in medroxyprogesterone acetate doses (95% CI: −47.6%, −29.5%, <i>p <</i> 0.001). …”
  19. 13099
  20. 13100